A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer

Peer Review reports

Original Submission
2 Oct 2012	Submitted	Original manuscript
10 Nov 2012	Reviewed	Reviewer Report - Paul Cottu
14 Nov 2012	Reviewed	Reviewer Report - Joel Parker
25 Dec 2012	Author responded	Author comments - Takayuki Kobayashi
Resubmission - Version 2
25 Dec 2012	Submitted	Manuscript version 2
5 Jan 2013	Reviewed	Reviewer Report - Joel Parker
13 Jan 2013	Reviewed	Reviewer Report - Paul Cottu
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
30 Jan 2013	Editorially accepted
6 Feb 2013	Article published	10.1186/1472-6890-13-5

Back to article page